EMEA-000309-PIP02-14

Key facts

Invented name
RoActemra
Active substance
tocilizumab
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0135/2015
PIP number
EMEA-000309-PIP02-14
Pharmaceutical form(s)
Solution for injection (in pre-filled syringe)
Condition(s) / indication(s)
Treatment of vasculitides
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Roche Registration Limited
United Kingdom
Tel. +41 6168 79411
Fax +41 6168 79233
E-mail: info.paediatrics@roche.com
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating